J0567 – Injection, cerliponase alfa, 1 mg
HCPCS Level II code · J codes: Drugs Administered Other Than Oral Method
HCPCS codeJ0567
- Long description
- Injection, cerliponase alfa, 1 mg
- Short description
- Inj., cerliponase alfa 1 mg
- Pricing indicator
51Drugs- Medicare coverage
CCarrier judgment – coverage decided by the Medicare contractor- BETOS category
O1EOther drugs- Added
- January 1, 2019
- Last change
- January 1, 2024 – No change
Frequently asked questions
What is HCPCS code J0567?
J0567 is a HCPCS Level II code for injection, cerliponase alfa, 1 mg.
Does Medicare cover J0567?
The HCPCS file lists coverage code C: Carrier judgment – coverage decided by the Medicare contractor. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby J codes
- J0515 – Injection, benztropine mesylate, per 1 mg
- J0517 – Injection, benralizumab, 1 mg
- J0520 – Injection, bethanechol chloride, myotonachol or urecholine, up to 5 mg
- J0525 – Injection, cefotetan disodium, 10 mg
- J0528 – Injection, fosfomycin disodium, 20 mg
- J0558 – Injection, penicillin g benzathine and penicillin g procaine, 100,000 units
- J0561 – Injection, penicillin g benzathine, 100,000 units
- J0565 – Injection, bezlotoxumab, 10 mg
- J0570 – Buprenorphine implant, 74.2 mg
- J0571 – Buprenorphine, oral, 1 mg
- J0572 – Buprenorphine/naloxone, oral, less than or equal to 3 mg buprenorphine
- J0573 – Buprenorphine/naloxone, oral, greater than 3 mg, but less than or equal to 6 mg buprenorphine
- J0574 – Buprenorphine/naloxone, oral, greater than 6 mg, but less than or equal to 10 mg buprenorphine
- J0575 – Buprenorphine/naloxone, oral, greater than 10 mg buprenorphine
- J0576 – Injection, buprenorphine extended-release (brixadi), 1 mg
- J0577 – Injection, buprenorphine extended-release (brixadi), less than or equal to 7 days of therapy
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.